The influenza vaccine for the 2024/2025 season provided moderate protection against influenza A and strong protection against ...

The 2024-2025 flu shot reduced hospitalizations by up to 78% in kids and 55% in adults. Flu cases are mostly caused by H1N1 ...

“Findings in this report show that vaccination with the 2024–2025 influenza vaccine reduced the likelihood of medically attended influenza and support CDC’s recommendation that all persons aged ≥6 ...

The meeting cancellation came one day before the CDC issued its weekly MMWR report, a scientific update on the latest ...

Flu vaccine makers may face a last-minute scramble to produce enough doses after an FDA advisory committee meeting was ...

So far this season, the vaccine's protection against flu hospitalization was at least 63% for children and at least 41% for adults. These estimates of effectiveness against hospitalization, released ...

Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...

Lab tests suggest a strain of the flu virus circulating this season may not be "well-recognized" by the flu vaccine.

1. The flu vaccine was 41% to 55% effective at preventing hospitalizations among adults this season. For children and adolescents, these figures ranged from 63% to 78%. 2. The flu shot's effectiveness ...

One of the worst flu seasons in years has reached its peak and is improving, officials with the Centers for Disease Control ...

The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss ...

Both the Finnish and the U.S. bird flu vaccines are made by CSL Seqirus but are different vaccines. In the summer, U.S.